Navigation Links
SenesTech Announces New Vice President of Business Development
Date:7/1/2009

FLAGSTAFF, Ariz., July 1 /PRNewswire/ -- SenesTech, Inc., a biotechnology corporation working on innovations for humane animal population management, announced the appointment of George M. Siegel as Vice President of Business Development.

Siegel has over 35 years of business development experience in executive management positions. He has served as Chairman of the Board of Directors for BrightStar Information Technology Group, Inc., Director of ILINC Communications, Inc., and President for RideAmerica Transportation Group, Parcelway Couriers Systems, Inc., Dynamex, and U.S. Messenger Service of Chicago, San Francisco.

"George's experience will be a valuable asset as he takes us to the world stage," said Everett Hale, CEO.

"I am excited to be part of SenesTech. I am enamored by the technology, which is so compelling, with the opportunity for growth and with the people. Loretta's (Dr. Loretta Mayer, Ph.D., Chief Scientific Officer and Chairman of the Board) knowledge is outstanding," George Siegel stated.

"As active Chairman of BrightStar, I worked in Southeast Asia and Australia," Siegel added. SenesTech plans to market their initial product, ContraPest to the agricultural ministries of Southeast Asia. Currently being field tested in Indonesia, ContraPest will dramatically improve rice yields in Southeast Asia by reducing the rice field rat population.

"Our private investors will be very pleased with George's expertise in taking us public," stated Hale from SenesTech's world headquarters in Flagstaff, AZ.

About George M. Siegel

George Siegel has over 35 years of management experience in founding and managing public companies. His broad expertise focused on business development and mergers and acquisitions includes founding and co-founding four public companies in the transportation and technology sectors.

About SenesTech, Inc.

SenesTech is a platform biotechnology company located on the Northern Arizona Center for Emerging Technology campus in Flagstaff, Arizona. SenesTech specializes in humane animal population management products for wildlife and companion animals. For more information about SenesTech's biotech innovations for chemical fertility management visit http://www.senestech.com.


'/>"/>
SOURCE SenesTech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. SenesTech Scientists Attend International Workshop on Fertility in New Zealand
2. SenesTech, Inc. Appoints Susan Airhart to Board of Directors
3. SenesTech, Inc. Commences Product Registration Process With Australian Government
4. SenesTech, Inc. Initiates Research Field Trials for ContraPest(R) in Indonesia
5. Arizona-Based SenesTech, Inc., Partners With Australia to Stop Starvation Due to Rice Shortages
6. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Second Quarter 2009 Results
7. Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal of Infusion Devices Agreement
8. Bion Announces Approval of New U.S. Patent that Broadens Protection for the Companys Livestock Waste Environmental Treatment Processes
9. Enigma Diagnostics Announces Successful Evaluation of the Enigma FL by the UKs Veterinary Laboratories Agency
10. Insmed Announces Addition to the Russell 3000(R) Index
11. BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... York, NY (PRWEB) , ... April 19, 2017 ... ... to combat Clostridium difficile (C. diff) infections through education and advocacy. Founded ... her life to a C. diff infection, the foundation has become the most-consulted ...
(Date:4/19/2017)... and PUNE, India , April 19, 2017 /PRNewswire/ ... "Membrane Microfiltration Market: Global Opportunity Analysis and Industry Forecast, 2014-2022 ," the global ... $12,858 million by 2022, registering a CAGR of 9.6% from 2016 to 2022. ... ... ...
(Date:4/19/2017)... WESTMINSTER, Colo. , April 19, 2017 ... specialty finance firm that provides senior debt to ... the closing of a $20 million senior secured ... orthobiologics company engaged in the development and commercialization ... of orthopedic injuries. Cerapedics, lead product, ...
(Date:4/19/2017)...   Thermo Fisher Scientific Inc . today ... SEpsis (MOSES) Study have been published in the ... Medicine . Researchers from the study, titled "Serial ... From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study," ... assay to assess risk for 28 day all-cause ...
Breaking Biology Technology:
(Date:4/5/2017)... SEATTLE , April 5, 2017  The Allen ... the Allen Cell Explorer: a one-of-a-kind portal and dynamic ... large-scale 3D imaging data, the first application of deep ... edited human stem cell lines and a growing suite ... the platform for these and future publicly available resources ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
Breaking Biology News(10 mins):